Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients.

Taniuchi K, Furihata M, Naganuma S, Sakaguchi M, Saibara T.

PLoS One. 2019 Jun 5;14(6):e0217920. doi: 10.1371/journal.pone.0217920. eCollection 2019.

2.

Hepatoid Adenocarcinoma With Enteroblastic Differentiation in the Sigmoid Colon: Lessons From a Rare Case.

Ogiwara S, Furihata M, Fukami K, Yamashita A, Yao T, Osada T.

Am J Gastroenterol. 2019 Apr;114(4):684-685. doi: 10.14309/ajg.0000000000000176. No abstract available.

PMID:
30848729
3.

Sclerosing Angiomatoid Nodular Transformation of the Spleen: Lessons from a Rare Case and Review of the Literature.

Nomura R, Tokumura H, Katayose Y, Nakayama F, Iwama N, Furihata M.

Intern Med. 2019 May 15;58(10):1433-1441. doi: 10.2169/internalmedicine.1948-18. Epub 2019 Jan 10. Review.

4.

WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4.

Taniuchi K, Furihata M, Naganuma S, Saibara T.

Cancer Med. 2018 Nov;7(11):5733-5751. doi: 10.1002/cam4.1837. Epub 2018 Oct 23.

5.

ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer.

Taniuchi K, Furihata M, Naganuma S, Saibara T.

Int J Oncol. 2018 Nov;53(5):2224-2240. doi: 10.3892/ijo.2018.4549. Epub 2018 Aug 31.

PMID:
30226582
6.

BCL7B, a predictor of poor prognosis of pancreatic cancers, promotes cell motility and invasion by influencing CREB signaling.

Taniuchi K, Furihata M, Naganuma S, Dabanaka K, Hanazaki K, Saibara T.

Am J Cancer Res. 2018 Mar 1;8(3):387-404. eCollection 2018.

7.

Murine remote preconditioning increases glucose uptake and suppresses gluconeogenesis in hepatocytes via a brain-liver neurocircuit, leading to counteracting glucose intolerance.

Kurabayashi A, Tanaka C, Matsumoto W, Naganuma S, Furihata M, Inoue K, Kakinuma Y.

Diabetes Res Clin Pract. 2018 May;139:288-299. doi: 10.1016/j.diabres.2018.03.009. Epub 2018 Mar 9.

PMID:
29526685
8.

SHISA2 enhances the aggressive phenotype in prostate cancer through the regulation of WNT5A expression.

Tamura K, Furihata M, Satake H, Hashida H, Kawada C, Osakabe H, Fukuhara H, Kumagai N, Iiyama T, Shuin T, Inoue K.

Oncol Lett. 2017 Dec;14(6):6650-6658. doi: 10.3892/ol.2017.7099. Epub 2017 Sep 28.

9.

Premedication with fast-acting oxycodone hydrochloride hydrate effectively reduced oxaliplatin-induced severe vascular pain.

Nagao S, Furihata M, Fukagawa K, Furihata T, Matsuhashi Y, Wada T.

J Infect Chemother. 2017 Jul;23(7):493-497. doi: 10.1016/j.jiac.2017.02.006. Epub 2017 Mar 10.

PMID:
28285948
10.

Expression of Cadherin-17 Promotes Metastasis in a Highly Bone Marrow Metastatic Murine Breast Cancer Model.

Okada T, Kurabayashi A, Akimitsu N, Furihata M.

Biomed Res Int. 2017;2017:8494286. doi: 10.1155/2017/8494286. Epub 2017 Jan 19.

11.

CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.

Tanouchi A, Taniuchi K, Furihata M, Naganuma S, Dabanaka K, Kimura M, Watanabe R, Kohsaki T, Shimizu T, Saito M, Hanazaki K, Saibara T.

J Exp Clin Cancer Res. 2016 Dec 5;35(1):190.

12.

Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.

Taniuchi K, Furihata M, Naganuma S, Dabanaka K, Hanazaki K, Saibara T.

Cancer Sci. 2016 Oct;107(10):1430-1442. doi: 10.1111/cas.13018. Epub 2016 Sep 2.

13.

Does massive intraabdominal free gas require surgical intervention?

Furihata T, Furihata M, Ishikawa K, Kosaka M, Satoh N, Kubota K.

World J Gastroenterol. 2016 Aug 28;22(32):7383-8. doi: 10.3748/wjg.v22.i32.7383.

14.

An Adult Gastric Duplication Cyst Mimicking a Gastrointestinal Stromal Tumor.

Yoda T, Furihata M, Nagao S, Wada T.

Intern Med. 2016;55(17):2401-4. doi: 10.2169/internalmedicine.55.6402. Epub 2016 Sep 1.

15.

Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells.

Tsuboi M, Taniuchi K, Furihata M, Naganuma S, Kimura M, Watanabe R, Shimizu T, Saito M, Dabanaka K, Hanazaki K, Saibara T.

Pancreatology. 2016 Sep-Oct;16(5):905-16. doi: 10.1016/j.pan.2016.07.002. Epub 2016 Jul 18.

PMID:
27453460
16.

The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model.

Ikezoe T, Yang J, Nishioka C, Pan B, Xu K, Furihata M, Nakamura K, Yurimoto H, Sakai Y, Honda G, Yokoyama A.

Bone Marrow Transplant. 2017 Jan;52(1):73-79. doi: 10.1038/bmt.2016.195. Epub 2016 Jul 18.

PMID:
27427915
17.

Silencing of ATPase Inhibitory Factor 1 Inhibits Cell Growth via Cell Cycle Arrest in Bladder Cancer.

Wei S, Fukuhara H, Kawada C, Kurabayashi A, Furihata M, Ogura S, Inoue K, Shuin T.

Pathobiology. 2015;82(5):224-32. doi: 10.1159/000439027. Epub 2015 Sep 19.

18.

Intramucosal Signet Ring Cell Gastric Cancer Diagnosed 15 Months after the Initial Endoscopic Examination.

Taniuchi K, Ookawauchi K, Kumon K, Sumiyoshi T, Iwata J, Furihata M, Nakamura T, Uchiumi J.

Case Rep Med. 2015;2015:479625. doi: 10.1155/2015/479625. Epub 2015 Jul 6.

19.

Performance of 5-aminolevulinic-acid-based photodynamic diagnosis for radical prostatectomy.

Fukuhara H, Inoue K, Kurabayashi A, Furihata M, Shuin T.

BMC Urol. 2015 Aug 1;15:78. doi: 10.1186/s12894-015-0073-y.

20.

Early Stages of Hyaline Membrane Formation Detected in Alveolar Mouths in Diffuse Alveolar-Damage-Associated Diseases: A Detailed Immunohistochemical Study.

Ohtsuki Y, Fujita J, Yoshinouchi T, Enzan H, Iguchi M, Lee GH, Furihata M.

Int J Surg Pathol. 2015 Oct;23(7):524-30. doi: 10.1177/1066896915582262. Epub 2015 Jul 16.

PMID:
26183849
21.

Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

Kurabayashi A, Inoue K, Fukuhara H, Karashima T, Fukata S, Kawada C, Shuin T, Furihata M.

Cancer Sci. 2015 Aug;106(8):1092-9. doi: 10.1111/cas.12711. Epub 2015 Jul 14.

22.

Repeated Duodenal Stump Perforation Using a Stapling Device Following Subtotal Gastrectomy With Roux-en-Y Reconstruction for Advanced Gastric Cancer: Lessons From a Rare Case.

Furihata T, Furihata M, Satoh N, Kosaka M, Ishikawa K, Kubota K.

Int Surg. 2015 Apr;100(4):726-32. doi: 10.9738/INTSURG-D-14-00266.1.

23.

Observation of tissues in open aqueous solution by atmospheric scanning electron microscopy: applicability to intraoperative cancer diagnosis.

Memtily N, Okada T, Ebihara T, Sato M, Kurabayashi A, Furihata M, Suga M, Nishiyama H, Mio K, Sato C.

Int J Oncol. 2015 May;46(5):1872-82. doi: 10.3892/ijo.2015.2905. Epub 2015 Feb 24.

24.

Investigation of aluminum and iron deposition on metaplastic bones in three patients with diffuse pulmonary ossification.

Ohtsuki Y, Mori K, Ohnishi H, Enzan H, Iguchi M, Lee GH, Furihata M.

Med Mol Morphol. 2015 Dec;48(4):235-8. doi: 10.1007/s00795-015-0096-1. Epub 2015 Jan 29.

PMID:
25631789
25.

A giant lymphatic cyst of the adrenal gland: report of a rare case and review of the literature.

Furihata M, Iida Y, Furihata T, Ito E.

Int Surg. 2015 Jan;100(1):2-8. doi: 10.9738/INTSURG-D-14-00125.1. Review.

26.

KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells.

Taniuchi K, Furihata M, Saibara T.

Neoplasia. 2014 Dec;16(12):1082-93. doi: 10.1016/j.neo.2014.10.007.

27.

Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity.

Taniuchi K, Furihata M, Hanazaki K, Iwasaki S, Tanaka K, Shimizu T, Saito M, Saibara T.

Pancreas. 2015 Mar;44(2):331-40. doi: 10.1097/MPA.0000000000000270.

28.

IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer.

Taniuchi K, Furihata M, Hanazaki K, Saito M, Saibara T.

Oncotarget. 2014 Aug 30;5(16):6832-45.

29.
30.

Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia.

Ohtsuki Y, Watanabe R, Kimura M, Nomura K, Maeda T, Kito K, Takeji M, Lee GH, Furihata M.

Med Mol Morphol. 2015 Jun;48(2):85-91. doi: 10.1007/s00795-014-0080-1. Epub 2014 Jun 8.

PMID:
24908068
31.

Antimuscle atrophy effect of nicotine targets muscle satellite cells partly through an α7 nicotinic receptor in a murine hindlimb ischemia model.

Kakinuma Y, Noguchi T, Okazaki K, Oikawa S, Iketani M, Kurabayashi A, Furihata M, Sato T.

Transl Res. 2014 Jul;164(1):32-45. doi: 10.1016/j.trsl.2014.02.005. Epub 2014 Apr 24. Erratum in: Transl Res. 2014 Dec;164(6):515. Kurabayashi, Mutsumi [corrected to Kurabayashi, Atsushi].

PMID:
24811002
32.

RUVBL1 directly binds actin filaments and induces formation of cell protrusions to promote pancreatic cancer cell invasion.

Taniuchi K, Furihata M, Iwasaki S, Tanaka K, Shimizu T, Saito M, Saibara T.

Int J Oncol. 2014 Jun;44(6):1945-54. doi: 10.3892/ijo.2014.2380. Epub 2014 Apr 10.

PMID:
24728183
33.

Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo.

Wei S, Fukuhara H, Chen G, Kawada C, Kurabayashi A, Furihata M, Inoue K, Shuin T.

Pathobiology. 2014;81(3):123-32. doi: 10.1159/000357622. Epub 2014 Mar 8.

34.

Immunohistochemical analyses of a case of extralobar pulmonary sequestration with chest pain in an adult.

Ohtsuki Y, Uomoto M, Hachisuka Y, Furihata M.

Indian J Pathol Microbiol. 2013 Oct-Dec;56(4):434-6. doi: 10.4103/0377-4929.125362.

35.

Application of 5-aminolevulinic acid-mediated photodynamic diagnosis to robot-assisted laparoscopic radical prostatectomy.

Inoue K, Ashida S, Fukuhara H, Iiyama T, Miyamura M, Kurabayashi A, Furihata M, Shuin T.

Urology. 2013 Nov;82(5):1175-8.

PMID:
24358486
36.

The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.

Fukuhara H, Inoue K, Kurabayashi A, Furihata M, Fujita H, Utsumi K, Sasaki J, Shuin T.

Photodiagnosis Photodyn Ther. 2013 Dec;10(4):399-409. doi: 10.1016/j.pdpdt.2013.03.003. Epub 2013 Apr 12.

PMID:
24284092
37.

Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?

Yamada R, Maeda N, Oguri H, Adachi Y, Takeuchi T, Furihata M, Fukaya T.

Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):96-100. doi: 10.1016/j.ejogrb.2013.08.003. Epub 2013 Aug 9.

PMID:
24017961
38.

Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.

Hagiya Y, Fukuhara H, Matsumoto K, Endo Y, Nakajima M, Tanaka T, Okura I, Kurabayashi A, Furihata M, Inoue K, Shuin T, Ogura S.

Photodiagnosis Photodyn Ther. 2013 Sep;10(3):288-95. doi: 10.1016/j.pdpdt.2013.02.001. Epub 2013 Mar 15.

PMID:
23993855
39.

Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide.

Ueda K, Tatsuguchi A, Saichi N, Toyama A, Tamura K, Furihata M, Takata R, Akamatsu S, Igarashi M, Nakayama M, Sato TA, Ogawa O, Fujioka T, Shuin T, Nakamura Y, Nakagawa H.

J Proteome Res. 2013 Oct 4;12(10):4497-506. doi: 10.1021/pr400547s. Epub 2013 Sep 11.

PMID:
23991666
40.

Conditional VHL gene deletion causes hypoglycemic death associated with disproportionately increased glucose uptake by hepatocytes through an upregulated IGF-I receptor.

Kurabayashi A, Kakinuma Y, Morita T, Inoue K, Sato T, Furihata M.

PLoS One. 2013 Jul 9;8(7):e69139. doi: 10.1371/journal.pone.0069139. Print 2013.

41.

A mental retardation gene, motopsin/prss12, modulates cell morphology by interaction with seizure-related gene 6.

Mitsui S, Hidaka C, Furihata M, Osako Y, Yuri K.

Biochem Biophys Res Commun. 2013 Jul 12;436(4):638-44. doi: 10.1016/j.bbrc.2013.04.112. Epub 2013 Jun 11.

PMID:
23770366
42.

Effects of macronutrient intake on thigh muscle mass during home-based walking training in middle-aged and older women.

Okazaki K, Yazawa D, Goto M, Kamijo YI, Furihata M, Gen-no H, Hamada K, Nose H.

Scand J Med Sci Sports. 2013 Oct;23(5):e286-92. doi: 10.1111/sms.12076. Epub 2013 May 7.

PMID:
23647307
43.

Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.

Inoue K, Fukuhara H, Kurabayashi A, Furihata M, Tsuda M, Nagakawa K, Fujita H, Utsumi K, Shuin T.

Cancer Sci. 2013 Jun;104(6):765-72. doi: 10.1111/cas.12147. Epub 2013 Apr 17.

44.

Immunohistochemical analysis of invasive micropapillary carcinoma pattern in four cases of gastric cancer.

Ohtsuki Y, Kuroda N, Yunoki S, Murakami S, Mizukami Y, Okada Y, Iguchi M, Lee GH, Furihata M.

Med Mol Morphol. 2013 Jun;46(2):114-21. doi: 10.1007/s00795-013-0037-9. Epub 2013 Mar 9.

PMID:
23471758
45.

PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype.

Dabanaka K, Chung S, Nakagawa H, Nakamura Y, Okabayashi T, Sugimoto T, Hanazaki K, Furihata M.

Med Mol Morphol. 2012 Dec;45(4):229-33. doi: 10.1007/s00795-011-0565-0. Epub 2012 Dec 7.

PMID:
23224602
46.

Role of altered expression of Nedd4L in the pathogenesis of systemic malignancies.

Kapoor S, Takeuchi T, Goto N, Kito Y, Furihata M.

Int J Exp Pathol. 2012 Dec;93(6):463; author reply 463-4. doi: 10.1111/j.1365-2613.2012.00834.x. Epub 2012 Oct 22. No abstract available.

47.

CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.

Nishioka C, Ikezoe T, Furihata M, Yang J, Serada S, Naka T, Nobumoto A, Kataoka S, Tsuda M, Udaka K, Yokoyama A.

Int J Cancer. 2013 May 1;132(9):2006-19. doi: 10.1002/ijc.27904. Epub 2012 Oct 30.

48.

Immunohistochemical and fluorescence in situ hybridization studies on noninvasive and invasive extramammary Paget's disease.

Hikita T, Ohtsuki Y, Maeda T, Furihata M.

Int J Surg Pathol. 2012 Oct;20(5):441-8.

PMID:
23001873
49.

Composite paraganglioma and ganglioneuroma in the retroperitoneum: a case report.

Ohtsuki Y, Watanabe R, Okada Y, Matsuka Y, Lee GH, Furihata M.

Med Mol Morphol. 2012 Jun;45(3):168-72. Epub 2012 Sep 22.

PMID:
23001299
50.

Overexpression of p53 protein in human tumors.

Inoue K, Kurabayashi A, Shuin T, Ohtsuki Y, Furihata M.

Med Mol Morphol. 2012 Jun;45(3):115-23. Epub 2012 Sep 22. Review.

PMID:
23001293

Supplemental Content

Loading ...
Support Center